Pricing Log in Create free account

Indaptus Therapeutics, Inc. (INDP) vs SL SCIENCE HLDG (SLBT)

Indaptus Therapeutics, Inc. and SL SCIENCE HLDG are both Biotechnology companies. Indaptus Therapeutics, Inc. and SL SCIENCE HLDG are of similar size ($504.7M and $485.3M). Across the 1 metrics below, Indaptus Therapeutics, Inc. leads on 1 and SL SCIENCE HLDG on 0.

Valuation

Metric INDP SLBT Biotechnology median
P/E n/m — 10.60
P/S n/m — 9.40
P/B 34.11 n/m 2.13
Price to free cash flow n/m — 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (231.90%) — (32.88%)
Free cash flow yield (3.79%) — (23.13%)

Profitability

Metric INDP SLBT Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% — 0.00%
Return on equity (318.04%) — (51.96%)
Return on assets (163.84%) — (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INDP SLBT Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 52.15% — 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric INDP SLBT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 19.48 4.44 4.97
Net debt to EBITDA 0.43 — 1.01

Dividend

Metric INDP SLBT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric INDP SLBT Biotechnology median
Market cap 485.32m 504.74m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack